SG11201506047PA - Prophylactic or therapeutic drug for constipation - Google Patents

Prophylactic or therapeutic drug for constipation

Info

Publication number
SG11201506047PA
SG11201506047PA SG11201506047PA SG11201506047PA SG11201506047PA SG 11201506047P A SG11201506047P A SG 11201506047PA SG 11201506047P A SG11201506047P A SG 11201506047PA SG 11201506047P A SG11201506047P A SG 11201506047PA SG 11201506047P A SG11201506047P A SG 11201506047PA
Authority
SG
Singapore
Prior art keywords
constipation
prophylactic
therapeutic drug
therapeutic
drug
Prior art date
Application number
SG11201506047PA
Inventor
Daisuke Yamamoto
Fusayo Io
Koji Yamamoto
Original Assignee
Taisho Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Taisho Pharmaceutical Co Ltd filed Critical Taisho Pharmaceutical Co Ltd
Publication of SG11201506047PA publication Critical patent/SG11201506047PA/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/351Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom not condensed with another ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1629Organic macromolecular compounds
    • A61K9/1652Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10Laxatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D309/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10Oxygen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00Preparations for use in therapy
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00Preparations for testing in vivo
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SG11201506047PA 2013-02-04 2014-02-03 Prophylactic or therapeutic drug for constipation SG11201506047PA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2013019754 2013-02-04
PCT/JP2014/052465 WO2014119787A1 (en) 2013-02-04 2014-02-03 Prophylactic or therapeutic drug for constipation

Publications (1)

Publication Number Publication Date
SG11201506047PA true SG11201506047PA (en) 2015-09-29

Family

ID=51262485

Family Applications (2)

Application Number Title Priority Date Filing Date
SG11201506047PA SG11201506047PA (en) 2013-02-04 2014-02-03 Prophylactic or therapeutic drug for constipation
SG10201700267PA SG10201700267PA (en) 2013-02-04 2014-02-03 Prophylactic or therapeutic drug for constipation

Family Applications After (1)

Application Number Title Priority Date Filing Date
SG10201700267PA SG10201700267PA (en) 2013-02-04 2014-02-03 Prophylactic or therapeutic drug for constipation

Country Status (18)

Country Link
US (1) US10022389B2 (en)
EP (1) EP2952206B1 (en)
JP (1) JP5807767B2 (en)
KR (1) KR102078433B1 (en)
CN (1) CN104955481B (en)
AU (1) AU2014213251B2 (en)
BR (1) BR112015017541A2 (en)
CA (1) CA2899834C (en)
ES (1) ES2694110T3 (en)
HK (1) HK1211479A1 (en)
IL (1) IL240192A (en)
MX (1) MX346453B (en)
MY (1) MY176162A (en)
PH (1) PH12015501696B1 (en)
RU (1) RU2648467C2 (en)
SG (2) SG11201506047PA (en)
TW (1) TWI659739B (en)
WO (1) WO2014119787A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2019142774A (en) * 2016-06-20 2019-08-29 大正製薬株式会社 Intestinal environment-improving agent

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2830424C3 (en) 1978-07-11 1982-04-15 Bayer Ag, 5090 Leverkusen alpha-glucosidase inhibitors
US5651988A (en) 1995-08-18 1997-07-29 Xyrofin Oy Combination osmotic and bulk forming laxatives
MXPA05001549A (en) 2002-08-08 2005-05-05 Kissei Pharmaceutical Pyrazole derivative, medicinal composition containing the same, medicinal use thereof, and intermediate for production thereof.
JP2004137245A (en) 2002-08-23 2004-05-13 Kissei Pharmaceut Co Ltd Pyrazole derivative, pharmaceutical composition containing the same, its pharmaceutical use and production intermediate
AU2003262262A1 (en) 2002-08-27 2004-03-19 Kissei Pharmaceutical Co., Ltd. Pyrazole derivatives, medicinal composition containing the same, and medicinal use thereof
JPWO2004050122A1 (en) 2002-12-04 2006-03-30 キッセイ薬品工業株式会社 Preventive or therapeutic agent for diseases caused by hyperglycemia
DE102004028241B4 (en) 2004-06-11 2007-09-13 Sanofi-Aventis Deutschland Gmbh New fluoroglycoside derivatives of pyrazoles, medicines containing these compounds and manufacture of these medicines
TWI387454B (en) 2004-09-02 2013-03-01 Sucampo Ag Method and composition for treating gastrointestinal disorder
EP2076503B1 (en) 2006-05-19 2013-07-17 Taisho Pharmaceutical Co., Ltd C-phenyl glycitol compound for the treatment of diabetes
CA2655937A1 (en) 2006-06-29 2008-01-03 Taisho Pharmaceutical Co., Ltd. C-phenyl 1-thioglucitol compound
TW200817424A (en) 2006-08-04 2008-04-16 Daiichi Sankyo Co Ltd Benzylphenyl glucopyranoside derivatives
TWI499414B (en) 2006-09-29 2015-09-11 Lexicon Pharmaceuticals Inc Inhibitors of sodium glucose co-transporter 2 and methods of their use
WO2008072726A1 (en) 2006-12-14 2008-06-19 Taisho Pharmaceutical Co., Ltd. 1-phenyl 1-thio-d-glucitol derivative
GB2447067A (en) 2007-02-20 2008-09-03 Branko R Babic Alteration of osmotic gradients by polyhydroxy compounds
KR101416561B1 (en) 2007-12-27 2014-07-08 깃세이 야쿠힌 고교 가부시키가이샤 Monosebacate of pyrazole derivative
EP2275430B1 (en) 2008-04-16 2012-05-16 Kissei Pharmaceutical Co., Ltd. Hemifumarate of a pyrazole derivative
CN102414191B (en) * 2009-02-23 2014-04-16 大正制药株式会社 4 -isopropylphenyl glucitol compounds as sgltl inhibitors
JP2013224263A (en) 2010-08-19 2013-10-31 Taisho Pharmaceutical Co Ltd 4-isopropylphenyl glucitol compound
EP2607360B1 (en) 2010-08-20 2015-08-19 Taisho Pharmaceutical Co., Ltd. 4-Isopropyl-6-methoxyphenyl glucitol compound
US8822674B2 (en) * 2010-08-20 2014-09-02 Taisho Pharmaceutical Co., Ltd Crystal form of 4-isopropylphenyl glucitol compound and process for production thereof
AR087701A1 (en) * 2011-08-31 2014-04-09 Japan Tobacco Inc PIRAZOL DERIVATIVES WITH SGLT1 INHIBITING ACTIVITY
BR112014027841B1 (en) 2012-05-07 2022-08-09 Kissei Pharmaceutical Co., Ltd USE OF PIRAZOLE DERIVATIVES IN THE MANUFACTURE OF A PHARMACEUTICAL TO PREVENT OR TREAT CONSTIPATION
HUE043868T2 (en) 2012-11-20 2019-09-30 Lexicon Pharmaceuticals Inc Inhibitors of sodium glucose cotransporter 1

Also Published As

Publication number Publication date
CA2899834C (en) 2020-09-01
WO2014119787A1 (en) 2014-08-07
MX346453B (en) 2017-03-17
CN104955481B (en) 2017-10-24
ES2694110T3 (en) 2018-12-18
EP2952206A4 (en) 2016-06-15
IL240192A0 (en) 2015-09-24
TWI659739B (en) 2019-05-21
AU2014213251A1 (en) 2015-08-27
JP5807767B2 (en) 2015-11-10
US20150374735A1 (en) 2015-12-31
RU2648467C2 (en) 2018-03-26
TW201517903A (en) 2015-05-16
RU2015137671A (en) 2017-03-10
JPWO2014119787A1 (en) 2017-01-26
MY176162A (en) 2020-07-24
SG10201700267PA (en) 2017-02-27
PH12015501696A1 (en) 2015-10-12
AU2014213251B2 (en) 2017-07-20
EP2952206A1 (en) 2015-12-09
US10022389B2 (en) 2018-07-17
KR20150112949A (en) 2015-10-07
CA2899834A1 (en) 2014-08-07
CN104955481A (en) 2015-09-30
HK1211479A1 (en) 2016-05-27
IL240192A (en) 2017-03-30
KR102078433B1 (en) 2020-02-17
MX2015010029A (en) 2015-10-30
BR112015017541A2 (en) 2017-07-11
PH12015501696B1 (en) 2015-10-12
EP2952206B1 (en) 2018-10-24

Similar Documents

Publication Publication Date Title
HRP20180684T1 (en) Drug combination
ZA201507576B (en) Pharmaceutical combination drug
GB201308440D0 (en) Therapeutic
HK1223833A1 (en) Pharmaceutical dosage forms
EP2968179A4 (en) Controlled release pharmaceutical dosage forms
ZA201600027B (en) Pharmaceutical preparation
EP3046556A4 (en) Combination drug therapy
GB201318668D0 (en) Sonosensitive therapeutic
HK1220633A1 (en) Pharmaceutical preparation comprising aminopyrazole derivative
HK1211479A1 (en) Prophylactic or therapeutic drug for constipation
ZA201506465B (en) Pharmaceutical preparation
GB201316662D0 (en) Pharmaceutical Combination
GB201320786D0 (en) Medicament
GB201305073D0 (en) Therapeutic means